SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-152478
Filing Date
2022-05-17
Accepted
2022-05-17 07:37:14
Documents
17
Period of Report
2022-05-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d328222d8k.htm   iXBRL 8-K 26799
2 EX-99.1 d328222dex991.htm EX-99.1 30080
6 GRAPHIC g328222g0517035330855.jpg GRAPHIC 812
7 GRAPHIC g328222g0517035338040.jpg GRAPHIC 6001
8 GRAPHIC g328222g79c45.jpg GRAPHIC 9451
9 GRAPHIC g328222page6.jpg GRAPHIC 13886
  Complete submission text file 0001193125-22-152478.txt   216833

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rprx-20220517.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20220517_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20220517_pre.xml EX-101.PRE 10817
11 EXTRACTED XBRL INSTANCE DOCUMENT d328222d8k_htm.xml XML 3298
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 22932253
SIC: 2834 Pharmaceutical Preparations